Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
Sponsor: Galderma R&D
Summary
The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.
Official title: A Prospective, Multicenter Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-06-03
Completion Date
2028-02-28
Last Updated
2026-06-22
Healthy Volunteers
Yes
Conditions
Interventions
Restylane Lyft with Lidocaine
Sterile gel of hyaluronic acid.
Locations (8)
Galderma Investigational Site # 8680
Westport, Connecticut, United States
Galderma Investigational Site # 8774
Boynton Beach, Florida, United States
Galderma Investigational Site # 7030
Coral Gables, Florida, United States
Galderma Investigational Site # 8682
Coral Gables, Florida, United States
Galderma Investigational Site # 7042
Atlanta, Georgia, United States
Galderma Investigational Site # 7043
Bethesda, Maryland, United States
Galderma Investigational Site # 7118
Nashville, Tennessee, United States
Galderma Investigational Site # 8662
Spring, Texas, United States